Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD

Kidney International

Volumn 81, Issue 12, 2012, Pages 1248-1253

  Jain, Arsh K ^a   Cuerden, Meaghan S ^a   McLeod, Ian ^a   Hemmelgarn, Brenda ^b   Akbari, Ayub ^c   Tonelli, Marcello ^d   Quinn, Rob R ^b   Oliver, Matt J ^e   Garg, Amit X ^a,f  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^f INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

Author keywords

Angiotensin converting enzyme inhibitors; chronic kidney disease; epidemiology and outcomes; glomerular filtration rate

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANADA; CHRONIC KIDNEY DISEASE; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG USE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; SEASONAL VARIATION; TIME SERIES ANALYSIS; TREATMENT DURATION; TREND STUDY;

EID: 84861711998     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.18     Document Type: Article

References (29)

1. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
2. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047. (Pubitemid 350074801)
3. Levin A, Hemmelgarn B, Culleton B, et al., for the Canadian Society of Nephrology. Guidelines for the management of chronic kidney disease. CMAJ 2008; 179: 1154-1162.
4. KDOQI. Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007; 49: S12-154.
5. Bailie GR, Eisele G, Liu L et al. Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects. Nephrol Dial Transplant 2005; 20: 1110.
6. Hsu C, Bates DW, Kuperman GJ et al. Blood pressure and angiotensin converting enzyme inhibitor use in hypertensive patients with chronic renal insufficiency. Am J Hypert 2001; 14: 1219-1225. (Pubitemid 33151478)
7. Israni A, Korzelius C, Townsend R et al. Management of chronic kidney disease in an academic primary care clinic. Am J Nephrol 2003; 23: 47-54. (Pubitemid 35316763)
8. Kausz AT, Khan SS, Abichandani R et al. Management of patients with chronic renal insufficiency in the Northeastern United States. J Am Soc Nephrol 2001; 12: 1501.
9. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100. (Pubitemid 41623371)
10. Levin A, Mendelsohn D Care and Referral of Adult Patients with Reduced Kidney Function: position paper from the Canadian Society of Nephrology. Canadian Society of Nephrology. http://www.csnscn.ca/atf/cf/%7Bfd785d1c-e27a- 489e-be3a-c75d43a753f1%7D/CSN% 20POSTION%20PAPER%20SEPT2006.PDF4, accessed on 14 March 2012.
11. National Kidney Foundation. Kidney Disease Outcomes Quality Initiative. http://www.kidney.org/professionals/KDOQI/guidelines-ckd/toc.htm4, accessed on 14 March 2012.
12. Akbari A, Swedko PJ, Clark HD et al. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch Intern Med 2004; 164: 1788-1792. (Pubitemid 39215649)
13. Wyatt C, Konduri V, Eng J et al. Reporting of estimated GFR in the primary care clinic. Am J Kidney Dis 2007; 49: 634-641. (Pubitemid 46654491)
14. Chaudhry M, Tregillus V, Platt H et al. Integrated strategies for CKD identification in BC: improved testing and care without increase in visitis to nephrologists. Canadian Society of Nephrology Conference Proceedings. 2005.
15. Rothberg MB, Kehoe ED, Courtemanche AL et al. Recognition and management of chronic kidney disease in an elderly ambulatory population. J Gen Intern Med 2008; 23: 1125-1130.
16. Hemmelgarn BR, Zhang J, Manns BJ et al. Nephrology visits and health care resource use before and after reporting estimated glomerular filtration rate. JAMA 2010; 303: 1151-1158.
17. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
18. Box GEP, Tiao GC. Intervention analysis with applications to economic and environmental problems. J Am Stat Assoc 1975; 70: 70-79.
19. Hux JE, Ivis F, Flintoft V et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002; 25: 512-516. (Pubitemid 41103345)
20. Levy AR, O'Brien BJ, Sellors C et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003; 10: 67-71. (Pubitemid 37028596)
21. Jong P, Gong Y, Liu PP et al. Care and outcomes of patients newly hospitalized for heart failure in the community treated by cardiologists compared with other specialists. Circulation 2003; 108: 184-191. (Pubitemid 36871301)
22. Al-Omran M, Tu JV, Johnston KW et al. Outcome of revascularization procedures for peripheral arterial occlusive disease in Ontario between 1991 and 1998: a population-based study. J Vasc Surg 2003; 38: 279-288. (Pubitemid 41130662)
23. Juurlink D, Preyra C, Croxford R et al. Canadian Institute for Health Information Discharge Abstract Database: A Validation Study. Institute for Clinical Evaluative Sciences: Toronto, 2006.
24. Levey AS, Greene T, Kusek JW et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000; 11: 155A.
25. Levy AR, O'Brien BJ, Sellors C et al. Coding accuracy of administrative drug claims in the Ontario Drug Benefit database. Can J Clin Pharmacol 2003; 10: 67-71. (Pubitemid 37028596)
26. Hux JE, Ivis F, Flintoft V et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002; 25: 512-516. (Pubitemid 41103345)
27. Tu K, Campbell NRC, Chen XL et al. Accuracy of administrative databases in identifying patients with hypertension. Open Med 2007; 1: e3-e5.
28. Levey AS, Coresh J, Greene T et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247-254. (Pubitemid 46768608)
29. Coresh J, Astor BC, McQuillan G et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 2002; 39: 920-929. (Pubitemid 34454210)